HOME >> MEDICINE >> NEWS
Drug Combination Including New "Super Aspirin" Drug Cuts Risk Of Death Or Second,,Heart Attack

DALLAS, June 23 -- In a growing class of blood-thinning drugs to treat heart attack, researchers have found one that seems to have a greater long-term benefit rather than only an immediate effect, according to a study released in today's Circulation: Journal of the American Heart Association.

The drug, lamifiban, is in a class of drugs called "platelet IIb/ IIIa receptor blockers," which prevent platelets from forming blood clots that obstruct blood vessels and cause heart attacks. Through a different mechanism, aspirin has a much weaker effect on platelets.

Lamifiban was used alone in varying doses and in combination with heparin, a blood-thinning agent.

The new drug combination may be used to treat patients who have severe chest pain or have had a non-Q-wave, or limited, heart attack. Standard in-hospital treatment for these individuals involves aspirin and heparin.

The study, co-authored by David J. Moliterno, M.D. is among several that are looking into ways to reduce heart attack survivors' high risk for death or a second heart attack in the first year following the attack, with the most critical period being in the first few weeks.

His study is unique in that it suggests a long-term benefit rather than an immediate effect alone. Even with standard treatment, "There is still room for improvement," says Moliterno, of the department of cardiology at The Cleveland Clinic Foundation, Cleveland, Ohio. The number of deaths and second heart attacks is high even at six months after the initial attack, he says.

The Circulation report, however, indicates that if heart attack patients survive the first 30 days, the chances of surviving past six months or even a year are better if they receive lamifiban compared with standard treatment.

"We don't know specifically how long before each individual patient is stabilized after a heart attack," says Moliterno. "Most deaths and second heart attacks tend to oc
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
22-Jun-1998


Page: 1 2

Related medicine news :

1. Combination treatment helps thyroid cancer patients live longer
2. Combination therapy, not medication alone, most effective for treating children with OCD
3. Combination of erection pill and testosterone gel may benefit men who fail treatment with pill alone
4. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
5. Combination PET/CT should be used to determine stage of non-small cell lung cancer
6. Combination of toxin and poison may be novel treatment for leukemia
7. Combination drug therapy could substantially improve symptoms of rheumatoid arthritis
8. Combination therapy does not appear to benefit cardiac patients before heart catheter procedure
9. Combination drug therapy offers hope for malaria treatment
10. Combination therapy significantly delays progression of benign prostatic hyperplasia
11. Combination, order of anti-HIV drugs make a difference in first-time recipients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... Presenting ... Benefit Administrators (SPBA) hosted “Expanding Your Success” with an educational emphasis. , ... focused on best practices for third party administrators (TPAs) related to health plan ...
(Date:9/19/2017)... ... September 19, 2017 , ... The Semper Fi Fund, one of ... release of a series of videos and a compelling documentary that provide unique insights ... United States as part of its ongoing mission. , Each of the videos focuses ...
(Date:9/19/2017)... ... September 19, 2017 , ... Public outrage over the toxins ... fallen on deaf ears, leaving the water industry itself to research, develop and ultimately ... of the curve in the field of natural alkaline water technologies, ...
(Date:9/19/2017)... (PRWEB) , ... September 19, ... ... memory-enhancing and cognitive health supplement developed by a neurosurgeon, has received a ... retailers. , Daily Brain Booster is currently available on the Wal-Mart ...
(Date:9/19/2017)... TX (PRWEB) , ... September 19, 2017 , ... ... the United States, named Dr. Howard Ng, as the new Medical Director of its ... be the new facility Medical Director of our Pflugerville- FM 685 location,” said Dr. ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
Breaking Medicine Technology:
Cached News: